Ipsen has named steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance, effective March 2020.
ADVERTISEMENT
Karl Naegler, who has been a partner at the investment company Gimv since 2011, has joined the competition. He is now Managing Partner at leading European venture capital firm Wellington Partners.
Norwegian biopharma company Zelluna Immunotherapy appointed erstwhile CSO Namir Hassan as Chief Executive Officer.
Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, has named Line Stigen Raquet as Chief Executive Officer.
Luxembourg-based Inceptua has named Stefan Fraenkel as its new CEO. Fraenkel has been in charge of creating the Inceptua’s business unit Inceptua Pharma since 2017.
The European Circular Bioeconomy Fund, which aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme, will be headed by Michael Brandkamp.
At the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.
Claus Haberda will be the new Managing Director at Roche Diagnostics GmbH, succeeding Ursula Redeker, who will return to Basel.
John Mattick has been appointed to the Board of Directors of Oxford-based research company Arctoris Ltd.
Swiss Lonza announced that CEO Marc Funk is leaving the company. Chairman Albert Baehny will take over as CEO on an ad interim basis until a successor is found.